Back
Bristol Myers Squibb Co. Vs. Gilead Sciences, Inc. Industry Stock Comparison
Buy
61
BMY
Bristol Myers Squibb Co.
Last Price:
$54.45
Seasonality Move:
12.83%
Sell
49
GILD
Gilead Sciences, Inc.
Last Price:
$121.35
Seasonality Move:
3.86%
Buy
61
Bristol Myers Squibb Co. (BMY)
is a Buy
Is Bristol Myers Squibb Co. a Buy, Sell or Hold?
-
The current Bristol Myers Squibb Co. [BMY] share price is $53.06. The Score for BMY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
BMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Gilead Sciences, Inc. (GILD)
is a Sell
Is Gilead Sciences, Inc. a Buy, Sell or Hold?
-
The current Gilead Sciences, Inc. [GILD] share price is $118.30. The Score for GILD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
GILD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMY Stock Price Chart
What is Bristol Myers Squibb Co.'s stock price today?
-
The Bristol Myers Squibb Co. share price today is $53.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
GILD Stock Price Chart
What is Gilead Sciences, Inc.'s stock price today?
-
The Gilead Sciences, Inc. share price today is $118.30Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GILD is experiencing slight selling pressure.
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.25 | Buy |
| Relative Strength Index (14 RSI): | 55.85 | Buy |
| Chaikin Money Flow: | 7587224 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.76 - 54.48) | Buy |
| Bollinger Bands (100): | (44.37 - 51.05) | Buy |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 37.8 | Sell |
| Chaikin Money Flow: | -2186907 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.4 - 124.76) | Sell |
| Bollinger Bands (100): | (114.42 - 123.84) | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.05 | Sell |
| 20-day SMA: | 53.3 | Sell |
| 50-day SMA: | 49.47 | Buy |
| 200-day SMA: | 48.49 | Buy |
| 8-day EMA: | 53.73 | Sell |
| 20-day EMA: | 52.92 | Buy |
| 50-day EMA: | 50.53 | Buy |
| 200-day EMA: | 49.25 | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.29 | Sell |
| 20-day SMA: | 122.14 | Sell |
| 50-day SMA: | 122.73 | Sell |
| 200-day SMA: | 113.81 | Buy |
| 8-day EMA: | 122.09 | Sell |
| 20-day EMA: | 122.63 | Sell |
| 50-day EMA: | 121.86 | Sell |
| 200-day EMA: | 113.62 | Buy |
Bristol Myers Squibb Co. Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and a decrease next year of $0.15 per share.
Gilead Sciences, Inc. Earnings Growth & GILD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.57 per share.
Bristol Myers Squibb Co. Technical Analysis
| Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||